Clinical and epidemiological profile of premature patients in the ambulatory of pediatric ophthalmology of a university health service
Main Article Content
Abstract
Introduction: Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina that affects low birth weight preterm babies and is the leading cause of blindness in children in developed and developing countries. Objective: Considering the importance of evaluating the pathology, this study aimed to carry out an epidemiological analysis of premature patients referred to the Pediatric Ophthalmology sector of Centro Universitário FMABC. Methods: Retrospective study of the medical records of patients referred to the Pediatric Ophthalmology sector of Centro Universitário FMABC, from March 2017 to December 2017, for ophthalmological evaluation due to suspected ROP (59 medical records). Results: Of the total of 43 eyes with the disease, two eyes fit in Zone II and 41 in Zone III. Seventeen eyes were classified as Stage 1, 16 as Stage 2, 4 as Stage 3, 4 as Stage 4 and 2 as Stage 5. Conclusion: The development of ROP was inversely proportional to weight and gestational age at birth. Treatment proved to be less prevalent in the disease.
Downloads
Article Details
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
2. Swan R, Kim SJ, Campbell JP, Chan RVP, Sonmez K, Taylor KD, et al. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. Ophthalmol Retina. 2018;2(9):949-62. https://doi.org/10.1016/j.oret.2018.01.016
3. Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, et al. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmology. 2016;123(7):1595-1600. https://doi.org/10.1016/j.ophtha.2016.03.026
4. Quinn GE. Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain. 2016;8:31-6. https://doi.org/10.2147/EB.S94436
5. Pallot C, Faure AS, Charvy C, Ternoy N, Muteau CL, Acar N, et al. Screening for Retinopathy of Prematurity: Insight into Optimizing Screening. Ophthalmic Res. 2018;59(4):228-34. https://doi.org/10.1159/000477622
6. Suelves AM, Shulman JP. Current screening and treatments in retinopathy of prematurity in the US. Eye Brain. 2016;8:37-43. https://doi.org/10.2147/EB.S94439
7. Reisner SH, Amir J, Shohat M, Krikler R, Nissenkorn I, Ben-Sira I. Retinopathy of prematurity: incidence and treatment. Arch Dis Child. 1985;60(8):698-701. https://doi.org/10.1136/adc.60.8.698
8. Fortes Filho JB, Eckert GU, Valiatti FB, Costa MC, Bonomo PP, Procianoy RS. Prevalência e fatores de risco para a retinopatia da prematuridade: estudo com 450 pré-termos de muito baixo peso. Rev Bras Oftalmol. 2009;68(1):22-9. https://doi.org/10.1590/S0034-72802009000100005